According to Vision Research Reports, the global medical enzyme technology market size is expected to hit around US$ 6.7 billion by 2027. It is projected to expand at a considerable CAGR during the forecast period.
Enzymes can be defined as complex proteins that catalyze a specific reaction or a chemical change in all parts of the body. The medical applications of enzymes have been in development, owing to their innate availability and magnitude of rewards offered in disease treatment and as diagnostic tools.
The rise in demand for medical enzyme technology can be attributed to the growing applications of enzymes for disease treatment and as diagnostic tools. In addition, the rising prevalence of cancer, increasing demand for cost effective treatment modes, and growing awareness among the population concerning the early diagnosis of disease contribute to the growth of the medical enzyme technology market. North America dominated the global medical enzyme technology market in 2019. The trend is anticipated to continue during the forecast period. The U.S. was the major revenue generating country in the region. Robust expansion of the market in North America can be attributed to increase in research & development and focus on the development of enzyme medication for the treatment of various chronic diseases.
Increase in biotech & diagnostic applications
Medical enzymes find applications in pharmaceutical and diagnostics industries. These are extensively used as therapeutic agents in the treatment of diseases associated with enzyme deficiency, and for performing diagnostic procedures such as ELISA. Enzymes are employed in various diagnostic and biotechnological applications such as DNA manipulation and sequencing. Additionally, the declining cost of DNA manipulation and sequencing is anticipated to act as a demand driver, leading to rise in usage of enzymes in research & biotechnology and diagnostic applications. Moreover, enzymes have applications in clinical diagnosis for the quantitative determination of health disorders, primarily diabetes. This is expected to contribute to the growth of the medical enzyme technology market during the forecast period.
Hydrolases Enzymes Dominated Global Market
In terms of enzyme type, the hydrolases segment is projected to account for a major share of the global medical enzyme technology market during the forecast period. Hydrolases include those enzymes, which have the ability to catalyze the cleavage of the substrate and in addition of water molecule to the resulting molecules. These enzymes aid in treatment of various diseases, owing to high stability, catalytic efficiency, commercial availability, and broad substrate specificity in a wide spectrum of bio-catalyzed processes.
Disease Treatment to be Key Application Area
Based on application, the disease treatment segment is anticipated to account for a major share of the global medical enzyme technology market during the forecast period. It is likely to maintain its dominance during the forecast period. Increasing application of medical enzyme technology in the development of therapeutics is driving the segment. The enzyme technology is being employed in the treatment of major diseases such as cancer, metabolic diseases, and lysosomal diseases.
Prominent Regions
The global medical enzyme technology market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global medical enzyme technology market in 2019. The expansion of the medical enzyme technology market in the region can be attributed to the rise in development of newer medicines based on enzymes and investment in research & development. The U.S. was a major country contributing to the expansion of the medical enzyme technology market in the region. The expansion of the market in the region can be primarily attributed to the growth of the market in the U.S. The growth of the market can be attributed to various factors, including strategic partnerships among market players to enhance their presence in the medical enzyme technology market. Additionally, the strong presence of market players in the region and increasing investments in research & development fuel the medical enzyme technology market in the region.
The medical enzyme technology market in Asia Pacific is estimated to expand at a significant CAGR from 2020 to 2030 driven by developing countries such as China and India. The expansion of the market in the region can be attributed to the rise in the number of contract research organizations offering drug discovery services. Additionally, increasing focus of big pharmaceutical companies on outsourcing drug discovery to countries in Asia, owing to the large target population and presence of skilled technicians further propels the medical enzyme technology market in the region.
Focus on Strategic Acquisitions and Partnerships by Key Players to Propel Global Market
The global medical enzyme technology market is fragmented in terms of number of players. Key players operating in the global medical enzyme technology market are Thermo Fisher Scientific Inc., Merck KGaA, Genzyme Corporation (Sanofi), Promega Corporation, Asahi Kasei Corporation, Takeda Pharmaceutical Company Limited, Cytiva (Danaher), Agilent Technologies, Inc., Sun Pharmaceutical Industries Ltd., Amano Enzyme Inc., and Novozymes A/S.
Market Segmentation
By Enzyme Type
By Application
By Region
A new study on the global medical enzyme technology market has been published by Vision Research Reports. It presents a wealth of information on key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the global medical enzyme technology market. The study offers valuable information about the global medical enzyme technology market to illustrate how the market would grow during the forecast period 2020-2027. The report provides the value and volume of the global medical enzyme technology market for the period 2020–2027, considering 2020 as the base year and 2027 as the forecast year. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study.
Key indicators of market growth, which include value chain as well as supply chain analyses, and Compound Annual Growth Rate (CAGR), are elucidated in the study in a comprehensive manner. This data can help readers interpret quantitative growth aspects of the global medical enzyme technology market during the forecast period.
An extensive analysis on business strategies of leading market players is also featured in study on the global medical enzyme technology market. This can help readers understand principal factors to foresee growth in the global medical enzyme technology market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the global market, which is expected to guide market players in making apt decisions in the future.
The report also delves into the competition landscape of the global medical enzyme technology market. Key players operating in the global market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global market report.
Key Questions Answered in Medical enzyme technology Market Study
- What are the key factors influencing the medical enzyme technology market in each region?
- What will be the CAGR of the global medical enzyme technology market between 2016 and 2027?
- What is the future scope and changing trends in technologies in the global medical enzyme technology market?
- Which factors will impede the growth of the global medical enzyme technology market during the forecast period?
- Which are the leading companies in the global medical enzyme technology market?
- Which region is set to expand at the fastest CAGR during the forecast period?
- What is the volume (Units) of different medical enzyme technology across all regions during the forecast period?
- Which segment will have the highest revenue globally in 2027 and which segment will expand at the fastest CAGR during the forecast period?
Research Methodology
A unique research methodology has been utilized by Vision Research Reports to conduct a comprehensive research on the growth of the global medical enzyme technology market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred to by analysts during the production of the global medical enzyme technology market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from medical enzyme technology industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in making Vision Research Reports estimates on the future prospects of the global market more reliable and accurate.
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
4.1. Definition
4.2. Market Indicators
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, 2020–2027
4.5. Global Medical Enzyme Technology Market Outlook
5.1. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
5.2. Technological Advancements
5.3. Major Research Institutes Involved
5.4. Disease Prevalence & Incidence Rate Globally in Key Countries
5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6.1. Introduction
6.2. Global Medical Enzyme Technology Market Value Share Analysis, by Enzyme Type
6.3. Global Medical Enzyme Technology Market Value Forecast, by Enzyme Type, 2020–2027
6.3.1. Digestive Enzymes
6.3.1.1. L-asparginase
6.3.1.2. Lactase
6.3.1.3. Others
6.3.2. Thrombolytic Enzymes
6.3.2.1. Streptokinase
6.3.2.2. Urokinase
6.3.2.3. Others
6.3.3. Hydrolases
6.3.3.1. Hyaluronidase
6.3.3.2. Lysozyme
6.3.3.3. Others
6.3.4. Others
6.4. Global Medical Enzyme Technology Market Attractiveness Analysis, by Enzyme Type
7.1. Introduction
7.2. Global Medical Enzyme Technology Market Value Share Analysis, by Application
7.3. Global Medical Enzyme Technology Market Value Forecast, by Application, 2020–2027
7.3.1. Disease Treatment
7.3.1.1. Cancer (Chemotherapy)
7.3.1.2. Metabolic Diseases
7.3.1.3. Others
7.3.2. Diagnostic Tools
7.3.2.1. Renal Disease
7.3.2.2. Cancer
7.3.2.3. Others
7.3.3. Biomedical Research
7.3.4. Others
7.4. Global Medical Enzyme Technology Market Attractiveness Analysis, by Application
8.1. Regional Outlook
8.2. Introduction
8.3. Global Medical Enzyme Technology Market Value Forecast, by Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa
8.4. Global Medical Enzyme Technology Market Attractiveness Analysis, by Region
9.1. Key Findings
9.2. North America Medical Enzyme Technology Market Value Forecast, by Enzyme Type, 2020–2027
9.2.1. Digestive Enzymes
9.2.1.1. L-asparginase
9.2.1.2. Lactase
9.2.1.3. Others
9.2.2. Thrombolytic Enzymes
9.2.2.1. Streptokinase
9.2.2.2. Urokinase
9.2.2.3. Others
9.2.3. Hydrolases
9.2.3.1. Hyaluronidase
9.2.3.2. Lysozyme
9.2.3.3. Others
9.2.4. Others
9.3. North America Medical Enzyme Technology Market Value Forecast, by Application, 2020–2027
9.3.1. Disease Treatment
9.3.1.1. Cancer (Chemotherapy)
9.3.1.2. Metabolic Diseases
9.3.1.3. Others
9.3.2. Diagnostic Tools
9.3.2.1. Renal Disease
9.3.2.2. Cancer
9.3.2.3. Others
9.3.3. Biomedical Research
9.3.4. Others
9.4. North America Medical Enzyme Technology Market Value Forecast, by Country, 2020–2027
9.4.1. U.S.
9.4.2. Canada
9.5. North America Medical Enzyme Technology Market Attractiveness Analysis
9.5.1. By Enzyme Type
9.5.2. By Application
9.5.3. By Country
10.1. Key Findings
10.2. Europe Medical Enzyme Technology Market Value Forecast, by Enzyme Type, 2020–2027
10.2.1. Digestive Enzymes
10.2.1.1. L-asparginase
10.2.1.2. Lactase
10.2.1.3. Others
10.2.2. Thrombolytic Enzymes
10.2.2.1. Streptokinase
10.2.2.2. Urokinase
10.2.2.3. Others
10.2.3. Hydrolases
10.2.3.1. Hyaluronidase
10.2.3.2. Lysozyme
10.2.3.3. Others
10.2.4. Others
10.3. Europe Medical Enzyme Technology Market Value Forecast, by Application, 2020–2027
10.3.1. Disease Treatment
10.3.1.1. Cancer (Chemotherapy)
10.3.1.2. Metabolic Diseases
10.3.1.3. Others
10.3.2. Diagnostic Tools
10.3.2.1. Renal Disease
10.3.2.2. Cancer
10.3.2.3. Others
10.3.3. Biomedical Research
10.3.4. Others
10.4. Europe Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2020–2027
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Europe Medical Enzyme Technology Market Attractiveness Analysis
10.5.1. By Enzyme Type
10.5.2. By Application
10.5.3. By Country/Sub-region
11.1. Key Findings
11.2. Asia Pacific Medical Enzyme Technology Market Value Forecast, By Enzyme Type, 2020-2027
11.2.1. Digestive Enzymes
11.2.1.1. L-asparginase
11.2.1.2. Lactase
11.2.1.3. Others
11.2.2. Thrombolytic Enzymes
11.2.2.1. Streptokinase
11.2.2.2. Urokinase
11.2.2.3. Others
11.2.3. Hydrolases
11.2.3.1. Hyaluronidase
11.2.3.2. Lysozyme
11.2.3.3. Others
11.2.4. Others
11.3. Asia Pacific Medical Enzyme Technology Market Value Forecast, by Application, 2020–2027
11.3.1. Disease Treatment
11.3.1.1. Cancer (Chemotherapy)
11.3.1.2. Metabolic Diseases
11.3.1.3. Others
11.3.2. Diagnostic Tools
11.3.2.1. Renal Disease
11.3.2.2. Cancer
11.3.2.3. Others
11.3.3. Biomedical Research
11.3.4. Others
11.4. Asia Pacific Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2020–2027
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Medical Enzyme Technology Market Attractiveness Analysis
11.5.1. By Enzyme Type
11.5.2. By Application
11.5.3. By Country/Sub-region
12.1. Key Findings
12.2. Latin America Medical Enzyme Technology Market Value Forecast, By Enzyme Type, 2020-2027
12.2.1. Digestive Enzymes
12.2.1.1. L-asparginase
12.2.1.2. Lactase
12.2.1.3. Others
12.2.2. Thrombolytic Enzymes
12.2.2.1. Streptokinase
12.2.2.2. Urokinase
12.2.2.3. Others
12.2.3. Hydrolases
12.2.3.1. Hyaluronidase
12.2.3.2. Lysozyme
12.2.3.3. Others
12.2.4. Others
12.3. Latin America Medical Enzyme Technology Market Value Forecast, by Application, 2020–2027
12.3.1. Disease Treatment
12.3.1.1. Cancer (Chemotherapy)
12.3.1.2. Metabolic Diseases
12.3.1.3. Others
12.3.2. Diagnostic Tools
12.3.2.1. Renal Disease
12.3.2.2. Cancer
12.3.2.3. Others
12.3.3. Biomedical Research
12.3.4. Others
12.4. Latin America Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2020–2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Medical Enzyme Technology Market Attractiveness Analysis
12.5.1. By Enzyme Type
12.5.2. By Application
12.5.3. By Country/Sub-region
13.1. Key Findings
13.2. Middle East & Africa Medical Enzyme Technology Market Value Forecast, By Enzyme Type, 2020-2027
13.2.1. Digestive Enzymes
13.2.1.1. L-asparginase
13.2.1.2. Lactase
13.2.1.3. Others
13.2.2. Thrombolytic Enzymes
13.2.2.1. Streptokinase
13.2.2.2. Urokinase
13.2.2.3. Others
13.2.3. Hydrolases
13.2.3.1. Hyaluronidase
13.2.3.2. Lysozyme
13.2.3.3. Others
13.2.4. Others
13.3. Middle East & Africa Medical Enzyme Technology Market Value Forecast, by Application, 2020–2027
13.3.1. Disease Treatment
13.3.1.1. Cancer (Chemotherapy)
13.3.1.2. Metabolic Diseases
13.3.1.3. Others
13.3.2. Diagnostic Tools
13.3.2.1. Renal Disease
13.3.2.2. Cancer
13.3.2.3. Others
13.3.3. Biomedical Research
13.3.4. Others
13.4. Middle East & Africa Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2020–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Medical Enzyme Technology Market Attractiveness Analysis
13.5.1. By Enzyme Type
13.5.2. By Application
13.5.3. By Country/Sub-region
14.1. Market Player - Competition Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company, 2019
14.3. Company Profiles
14.3.1. Thermo Fisher Scientific Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. Strategic Overview
14.3.1.5. SWOT Analysis
14.3.2. Merck KGaA
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. Strategic Overview
14.3.2.5. SWOT Analysis
14.3.3. Genzyme Corporation (Sanofi)
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. Strategic Overview
14.3.3.5. SWOT Analysis
14.3.4. Promega Corporation
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. Strategic Overview
14.3.4.5. SWOT Analysis
14.3.5. Asahi Kasei Corporation
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. Strategic Overview
14.3.5.5. SWOT Analysis
14.3.6. Takeda Pharmaceutical Company Limited
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. Strategic Overview
14.3.6.5. SWOT Analysis
14.3.7. Cytiva (Danaher)
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. Strategic Overview
14.3.7.5. SWOT Analysis
14.3.8. Agilent Technologies, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. Strategic Overview
14.3.8.5. SWOT Analysis
14.3.9. Sun Pharmaceutical Industries Ltd.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. Strategic Overview
14.3.9.5. SWOT Analysis
14.3.10. Amano Enzyme Inc.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. Strategic Overview
14.3.10.5. SWOT Analysis
14.3.11. Novozymes A/S
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Financial Overview
14.3.11.3. Product Portfolio
14.3.11.4. Strategic Overview
14.3.11.5. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers